Avoro Capital Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,024,400
| Closed | -$8.62M | – | 44 |
|
|
2021
Q2 | $8.62M | Sell |
2,024,400
-1,525,600
| -43% | -$6.5M | 0.15% | 43 |
|
|
2021
Q1 | $18.9M | Hold |
3,550,000
| – | – | 0.33% | 36 |
|
|
2020
Q4 | $19.1M | Sell |
3,550,000
-7,450,000
| -68% | -$40.2M | 0.33% | 33 |
|
|
2020
Q3 | $87.8M | Buy |
11,000,000
+1,000,000
| +10% | +$7.98M | 1.25% | 16 |
|
|
2020
Q2 | $100M | Buy |
+10,000,000
| New | +$100M | 1.98% | 16 |
|
|
2015
Q3 | – | Sell |
-183,900
| Closed | -$3.37M | – | 30 |
|
|
2015
Q2 | $3.37M | Buy |
+183,900
| New | +$3.37M | 0.93% | 24 |
|